Showing results (601-610 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|April 14, 2007
Uncommon tumors and exceptional therapies: paradox or paradigm?Fadi Braiteh, Razelle Kurzrock
Molecular Cancer Therapeutics|April 14, 2007
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agentsWalter M Stadler
Molecular Cancer Therapeutics|April 14, 2007
Levels of p27(kip1) determine Aplidin sensitivityVictoria Moneo, Beatriz G Serelde, Juan F M Leal, et al.
Molecular Cancer Therapeutics|April 14, 2007
Identification of a novel inhibitor of urokinase-type plasminogen activatorMing Zhu, Vijay M Gokhale, Lajos Szabo, et al.
Molecular Cancer Therapeutics|April 14, 2007
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, et al.
Molecular Cancer Therapeutics|April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cellsSangkil Nam, Ann Williams, Adina Vultur, et al.
Molecular Cancer Therapeutics|July 11, 2007
Regulation of mitosis via mitotic kinases: new opportunities for cancer managementTravis L Schmit, Nihal Ahmad
Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.
Pageof 599